# GIVLAARI

NDC: 71336-1001
Generic name: givosiran sodium
Labeler / Manufacturer: Alnylam Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20191212

FDA application: NDA212194

## Active ingredients

- GIVOSIRAN SODIUM: 189 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71336-1001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71336-1001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=167e663c-11e1-497b-a3fc-951d65d58eaa
